COVID-19: Impact of and on Diabetes.

COVID-19 Coronavirus Diabetes Hyperglycaemia Service development

Journal

Diabetes therapy : research, treatment and education of diabetes and related disorders
ISSN: 1869-6953
Titre abrégé: Diabetes Ther
Pays: United States
ID NLM: 101539025

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 18 05 2020
pubmed: 9 6 2020
medline: 9 6 2020
entrez: 8 6 2020
Statut: ppublish

Résumé

Diabetes has been identified as a pre-existing health condition linked with worse outcomes following coronavirus disease 2019 infection. Here we explore the association between hyperglycaemia and more severe illness, the impact of the pandemic on diabetes service delivery, and the resultant opportunities for innovation.

Identifiants

pubmed: 32506222
doi: 10.1007/s13300-020-00847-5
pii: 10.1007/s13300-020-00847-5
pmc: PMC7275119
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1429-1435

Références

Diabetes Care. 2013 Oct;36(10):3333-6
pubmed: 23835687
Diabetes Technol Ther. 2020 Jun;22(6):449-453
pubmed: 32383989
Diabetes Res Clin Pract. 2020 Apr;162:108132
pubmed: 32234504
Lancet Diabetes Endocrinol. 2019 Mar;7(3):221-230
pubmed: 30115599
Crit Care. 2013 Jul 24;17(4):R159
pubmed: 23883613
Nature. 2013 Mar 14;495(7440):251-4
pubmed: 23486063
Diabetes Res Clin Pract. 2020 Apr;162:108142
pubmed: 32278764
Am J Med. 2018 Feb;131(2):165-172
pubmed: 28943384
Eur J Pharmacol. 2016 Nov 15;791:735-740
pubmed: 27756605
Endocr Rev. 2020 Jun 1;41(3):
pubmed: 32294179
J Diabetes Sci Technol. 2020 Jul;14(4):813-821
pubmed: 32389027
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):303-310
pubmed: 32298981
Circ Res. 2016 Aug 19;119(5):652-65
pubmed: 27418629
N Engl J Med. 2018 Aug 09;379(6):547-556
pubmed: 29940126
Acta Diabetol. 2010 Sep;47(3):193-9
pubmed: 19333547
Diabet Med. 2020 May;37(5):723-725
pubmed: 32242990
Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550
pubmed: 32334646
Immunity. 2018 Jul 17;49(1):164-177.e6
pubmed: 29958802
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3
pubmed: 32369736
Diabetes Metab Res Rev. 2020 Mar 31;:e3319
pubmed: 32233013
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Metabolism. 2020 Jun;107:154216
pubmed: 32220612
J Clin Endocrinol Metab. 2020 May 1;105(5):
pubmed: 32232480
J Clin Endocrinol Metab. 2003 Mar;88(3):1082-8
pubmed: 12629088
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Viruses. 2019 Jan 14;11(1):
pubmed: 30646565
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Int J Infect Dis. 2020 May;94:91-95
pubmed: 32173574
Am J Med Sci. 2016 Feb;351(2):201-11
pubmed: 26897277

Auteurs

Jonathan Schofield (J)

Manchester Diabetes Centre, Manchester University Hospitals NHS Foundation Trust, Manchester, UK. jschofield@doctors.org.uk.
Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK. jschofield@doctors.org.uk.

Lalantha Leelarathna (L)

Manchester Diabetes Centre, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.

Hood Thabit (H)

Manchester Diabetes Centre, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.

Classifications MeSH